Skip to content
Search AI Powered

Latest Stories

Cannabis & Cancer: The Evidence Is In—So Why Is the Medical Establishment Still Dragging Its Feet?

A new meta-analysis of 10,000+ studies confirms what patients have known for decades: cannabis helps cancer care. The real question now is, when will healthcare and policy finally reflect the evidence?

image of a circle of doctors and surgeons standing over and looking at a patient on operating room table

New Study Confirms Medical Cannabis Benefits in Cancer Care—Time for Policy to Catch Up

If you've ever watched a loved one battle cancer—or been on that journey yourself—you already know the harsh truth: the pain is real, the nausea is relentless, the appetite is gone, and the side effects of treatment often feel worse than the disease. So when patients say cannabis helps, it shouldn’t take 10,000 studies for the medical community to take them seriously.

And yet, here we are.


A groundbreaking meta-analysis published in Frontiers in Oncology this month reviewed more than 10,000 peer-reviewed studies covering nearly 40,000 individual data points related to medical cannabis and cancer. The conclusion? Cannabis offers “significant” therapeutic benefits for patients living with cancer—particularly in managing pain, inflammation, appetite loss, and chemotherapy-induced nausea. The research even hints at potential anticancer properties, though that part of the science is still early and evolving.

“Our findings strongly suggest that medical cannabis can significantly improve quality of life for cancer patients,” said Dr. Marcin Chwistek, a palliative care specialist who contributed to the review.

That should be a mic-drop moment. But instead of making headlines, this kind of evidence often gets buried under layers of stigma, regulatory inertia, and pharmaceutical gatekeeping.

What the Study Actually Says (and Why It Matters)

Unlike many smaller or anecdotal reports, this was not a one-off trial or industry-funded white paper. This was the first large-scale systematic review to pull from real-world patient data, clinical trials, lab studies, and pre-clinical research to paint a global picture of how cannabis interacts with cancer care.

Key findings include:

  • Robust support for using cannabis to relieve chronic pain in cancer patients, often with fewer side effects than opioids.
  • Evidence that cannabis can reduce nausea, vomiting, and anorexia caused by chemotherapy.
  • Signals that cannabinoids may have anti-inflammatory and even tumor-suppressing properties—though this area still needs deeper exploration.
  • Patients overwhelmingly reported improved quality of life, including better sleep, reduced anxiety, and improved mood.

So why isn’t this the standard of care yet?

A Legal Industry, Still Treated Like a Crime Scene

Here’s where the frustration—and hypocrisy—kicks in. Despite medical cannabis being legal in 38 U.S. states and a growing list of countries worldwide, patients and doctors alike are operating in a legal gray zone.

  • Federal law in the U.S. still classifies cannabis as a Schedule I drug—on par with heroin.
  • Physicians often lack training or confidence to prescribe cannabis, thanks to outdated curricula and risk-averse healthcare systems.
  • Patients have to self-medicate, navigating dispensary menus without guidance while dodging insurance hurdles and social judgment.

If this were any other drug—especially one backed by thousands of studies—there would be a pharma giant running national commercials, lobbyists pushing legislation, and glossy brochures in every hospital waiting room. But cannabis?

Still controversial.

Still marginalized.

It’s Not Just Medical: It’s Political

The Guardian’s recent coverage of this study rightfully noted the disconnect between mounting scientific evidence and glacial policy change. Cannabis remains a politically charged substance, often debated through the lens of moral panic rather than clinical data.

Even in places where medical cannabis is legal, access is uneven. Many cancer patients—especially in rural, lower-income, or conservative regions—struggle to get legal access or face stigma from their care teams. Others simply can’t afford the out-of-pocket costs because cannabis isn’t covered by insurance.

This isn’t just about science anymore—it’s about power, politics, and who gets to control healthcare narratives.

The Blunt Take: Let the Science Lead, Not the Stigma

We’ve reached the tipping point. The science says cannabis helps. The patients say cannabis helps. So what are we waiting for?

If we’re serious about evidence-based medicine, it’s time to:

  • Deschedule cannabis federally and integrate it into mainstream care.
  • Mandate cannabis education in medical schools and continuing education programs.
  • Fund longitudinal research into cannabis not just as a palliative tool, but as a potential anticancer agent.
  • Give patients access, insurance support, and dignity—without treating them like criminals or guinea pigs.

This isn’t a radical idea. It’s a rational one.

Because if 10,000 studies don’t prove the point, maybe it’s time to stop questioning the plant—and start questioning the system.

Want more radically honest cannabis coverage?

Sign up for The Bluntness newsletter—where we break through the noise with smart takes, deep dives, and unfiltered commentary on the future of cannabis, psychedelics, culture, and commerce.

More For You

Comprehensive Glossary of Cannabis Terminology - The Bluntness
Cannabis Terminology - The Bluntness
Photo by Margo Amala on Unsplash

Are You Ready to Master Cannabis Lingo? Explore Essential Terms Now

This glossary covers key cannabis-related terms that can help consumers better understand the cannabis industry, products, and their effects. Whether you're new to cannabis or looking to deepen your knowledge, these definitions offer clarity on common terms you might encounter.

Cannabis Basics: What is Cannabis?

Cannabis is a fascinating plant species that includes three main types: Cannabis sativa, Cannabis indica, and Cannabis ruderalis. Each of these species has unique characteristics and effects. The cannabis plant is a complex organism, rich in various compounds such as cannabinoids, terpenes, and flavonoids. These compounds contribute to the plant’s diverse range of effects and therapeutic benefits. Cannabis plants are cultivated for both medicinal and recreational purposes, and they can be consumed in multiple forms, including dried flower, extracts, and edibles. Whether you’re interested in the energizing effects of Cannabis sativa, the relaxing properties of Cannabis indica, or the unique traits of Cannabis ruderalis, there’s a cannabis plant to suit every need.

Cannabis Products: Cannabis Extracts

Cannabis extracts are highly potent products derived from the cannabis plant using various extraction methods, such as solvents or CO2. These extracts are concentrated forms of cannabis that can be used in several ways, including dabbing, vaporizing, or as ingredients in edibles and topicals. There are several types of cannabis extracts, each with its own texture and potency, including wax, shatter, oil, and crumble. These products are often favored for their high cannabinoid content and are commonly used for medicinal purposes, such as pain relief and anxiety management. Whether you’re looking for a powerful dabbing experience or a potent ingredient for your homemade edibles, cannabis extracts offer a versatile and effective option.

Keep ReadingShow less
Kanye West Is Spiraling—And Our Mental Health System Is Letting It Happen - The Bluntness
Kanye West Is Spiraling—And Our Mental Health System Is Letting It Happen - The Bluntness
Photo by Axel Antas-Bergkvist on Unsplash

Kanye West Is Spiraling—And Our Mental Health System Is Letting It Happen - The Bluntness

Kanye West, aka Ye, isn’t just trending—he’s unraveling in real time. And instead of intervention, we get viral clips, condemnation, and an audience watching a man self-destruct. His latest stunt? Airing a Super Bowl ad promoting a swastika-emblazoned Yeezy shirt on his site—a move so blatantly antisemitic that even the most die-hard supporters had to step back. This act garnered significant media coverage, leading to brands cutting ties and agents dropping him. His social media account faced scrutiny and was ultimately deleted after a history of controversial postings. But here’s the problem: canceling Kanye doesn’t fix Kanye.

At this point, the question isn’t whether his actions are inexcusable (they are). The question is, what happens when one of the world’s most influential figures is also one of the most untreated cases of mental illness in pop culture history?

Keep ReadingShow less
Image of the famous Welcome to Fabulous Las Vegas Nevada sign in Las Vegas, NV
Nevada’s First Cannabis Lounge Closes—And It’s a Symptom of a Bigger Problem
Photo by David Vives on Unsplash

Nevada’s First Cannabis Lounge Closes—And It’s a Symptom of a Bigger Problem

Tags: Cannabis Lounges, Nevada, Cannabis Policy, Legalization, Industry Reform, Small Business

When Smoke and Mirrors, Nevada’s first state-licensed cannabis consumption lounge, opened in early 2024, it was hailed as a major milestone for the state’s adult-use market and a potential blueprint for others across the country. Less than a year later, it's permanently closed.

Keep ReadingShow less
map of medical and recreational cannabis retailers in state of New York
NY Cannabis Program Under Fire for Misconduct
NY Cannabis Program Under Fire for Misconduct

Legal Weed, Legit?

New York’s legal cannabis industry was supposed to be the nation’s model of equity and regulation. Instead, it’s quickly becoming a cautionary tale. And the latest news doesn’t just raise eyebrows—it should set off alarms across the entire industry.

According to an April 7 report byThe New York Times, New York State regulators are conducting a sweeping investigation into some of the biggest cannabis companies operating in the state—Stiiizy, Grön, Mfused, and others—over allegations of using out-of-state or unauthorized cannabis to produce products for legal dispensaries. It’s a practice insiders call “inversion”—and it’s been the industry’s not-so-secret open secret for years.

Keep ReadingShow less
image of California coast, pacific coast highway at sunset
How Overregulation Crushed California’s Gold Flora—And Why Other States Should Be Worried
Photo by Matthew Hamilton on Unsplash

Overregulation Kills Gold Flora

When California-based Gold Flora entered the legal cannabis scene, the company was poised to dominate. Backed by serious money and a sprawling, vertically integrated operation—from a 100,000-square-foot cultivation campus in the desert to marquee dispensaries in West Hollywood and San Jose—Gold Flora wasn't just riding the green wave. It was supposed to be the wave.

But by the end of March 2025, the company had filed for receivership, its assets now headed to auction. And while headlines cite "merger woes" and "market conditions," the real culprit behind Gold Flora’s collapse is far more systemic: a regulatory stranglehold that has quietly choked the life out of California’s once-promising cannabis economy.

Keep ReadingShow less